Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa TherapyRichard Gray, Carl Counsell, Smitaa Patel et al.|JAMA Neurology|2021Cited by 61
Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic reviewElizabeth L. Turner, Hui‐Jie Lee, Christina Easter et al.|The Lancet Global Health|2021Cited by 32